Piscataway, NJ, March 8, 2024–Camber Pharmaceuticals is pleased to announce the addition of Icosapent Ethyl Capsules to its current portfolio.
Icosapent Ethyl Capsules are an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
Icosapent Ethyl Capsules are available in:
-
- 0.5 gram – 240 count bottles
- 1 gram – 120 count bottles
To find out more about Icosapent Ethyl Capsule, please visit https://www.camberpharma.com/icosapent
